furin
crucial
member
mammalian
subtilas
collect
known
proprotein
convertas
pc
proprotein
convertas
subtilisinkexin
pcsk
membran
bound
type
proteas
respons
tissuespecif
endoproteolyt
cleavag
larg
varieti
inact
protein
precursor
gener
sequenc
motif
kr
x
n
r
n
x
usual
amino
acid
cy
lead
function
activ
secretori
protein
polypeptid
among
known
furin
substrat
precursor
hormon
neuropeptid
growth
factor
adhes
molecul
receptor
surfac
protein
viral
glycoprotein
bacteri
toxin
base
find
accumul
studi
literatur
furin
strongli
link
tumorgenesi
hormon
diseas
neurolog
dementia
varieti
infecti
diseas
caus
ebola
avian
hong
kong
hiv
human
sar
corona
virus
well
bacteri
pathogenesi
due
anthrax
toxin
aerolysin
etc
owe
result
enzym
consid
potenti
prognost
factor
sever
diseas
therefor
mani
research
includ
us
becam
interest
develop
potent
specif
furin
inhibitor
may
possess
import
biochem
clinic
therapeut
applic
sever
macromolecul
small
compound
furin
inhibitor
report
literatur
review
macromolecul
furin
inhibitor
protein
type
either
endogen
biolog
engin
small
molecul
inhibitor
larg
synthet
peptid
peptidomimet
fulli
nonpeptid
compound
owe
increas
stabil
enhanc
bioavail
improv
drug
like
properti
easi
access
synthet
mean
small
molecul
inhibitor
alway
prefer
protein
therapeut
use
among
variou
inhibitor
design
strategi
far
report
prodomain
approach
attract
attent
effect
versatil
sometim
enhanc
select
besid
approach
incorpor
noncleav
pseudo
peptid
bond
unnatur
amino
acid
site
potent
peptid
substrat
base
prodomain
physiolog
protein
sequenc
also
use
success
design
inhibitor
pc
enzym
base
somewhat
similar
idea
herein
report
first
time
new
innov
strategi
design
potent
furin
inhibitor
approach
primarili
base
special
construct
unnatur
amino
acid
call
eda
enediynyl
amino
acid
incorpor
cleavag
site
prodomain
sequenc
furin
whose
primari
role
regul
proteas
activ
provid
proper
fold
bind
show
incorpor
highli
reactiv
betaturn
induc
aromat
eda
moieti
scissil
amid
bond
prodomain
peptid
human
furin
led
potent
furininhibitor
inhibit
constant
ki
low
nm
rang
mani
year
enediyn
deriv
known
bind
cleav
dna
especi
cancer
cell
oxid
action
occur
via
situ
gener
bisrad
bergman
cycloaromat
reaction
eas
cycliz
depend
natur
structur
enediyn
thu
cyclic
diyn
member
size
well
azaenediyn
shown
effici
undergo
bergman
cycliz
induct
light
metal
ion
elev
temperatur
due
low
activ
barrier
review
due
uniqu
abil
cycliz
produc
reactiv
bisrad
sever
enediyn
deriv
design
reactiv
speci
especi
dna
degrad
far
sever
enediyn
synthet
fungal
metabolit
origin
shown
display
strong
antitumor
activ
subsequ
compound
approv
anticanc
drug
recent
studi
jone
et
al
examin
viabil
protein
target
thermal
photoactiv
enediyn
deriv
confirm
molecular
level
shown
specif
design
enediyn
deriv
degrad
protein
suitabl
condit
base
observ
hypothes
function
deriv
may
also
interact
catalyt
activ
protein
proteas
like
furin
therebi
regul
enzymat
function
activ
effici
bind
target
enzym
furin
propos
moieti
must
carri
furin
recognit
peptid
sequenc
thu
prepar
novel
enediynyl
peptid
use
combin
organ
peptid
chemistri
demonstr
potent
furin
inhibitori
activ
vitro
cellular
model
first
describ
synthesi
fmocprotect
eda
incorpor
furin
substrat
name
peptid
furin
cleavag
site
biochem
studi
show
antifurin
activ
peptid
analog
toward
fluorogen
peptid
substrat
well
physiolog
precursor
protein
growth
factor
propdgfa
b
provegfc
describ
present
studi
aromat
enediyn
compound
chemic
highli
reactiv
easili
gener
upon
heat
reactiv
bisrad
speci
via
bergman
cycloaromat
reaction
possibl
reactiv
intermedi
may
react
one
catalyt
amino
acid
residu
ser
asp
pcenzym
lead
chemic
modif
latter
notion
support
sever
studi
involv
interact
amino
acid
either
free
within
protein
sequenc
base
rational
propos
type
molecul
may
therefor
inhibit
proteas
activ
enzym
test
hypothesi
first
synthes
sever
aromat
enediyn
deriv
examin
vitro
effect
proteolyt
activ
three
key
member
pcfamili
enzym
name
furin
vitro
enzym
assay
pc
bocrvrrmca
substrat
absenc
presenc
variou
synthet
aromat
enediyn
compound
fig
indic
weak
modest
inhibitori
activ
compound
among
pc
examin
potent
inhibitori
activ
note
compound
display
valu
furin
highest
inhibitori
activ
also
note
valu
except
minor
proteas
activ
effect
toward
enediyn
compound
exhibit
inhibitori
effect
toward
furin
valu
rang
depend
natur
enzym
enediyn
compound
use
first
report
pcinhibitori
activ
enediyn
compound
find
prompt
us
idea
incorpor
enediyn
function
within
peptid
sequenc
may
enhanc
potenc
select
furin
inhibit
accomplish
design
synthes
enediynyl
amino
acid
eda
deriv
amino
termin
protect
fmoc
carbonyl
group
directli
use
solid
phase
peptid
synthesi
synthesi
fmoceda
accomplish
adopt
chemistri
similar
earlier
report
us
multipl
step
involv
synthesi
shown
schemat
self
explanatori
way
fig
synthet
detail
procedur
describ
materi
method
section
incorpor
eda
unit
select
sequenc
human
furin
prodomain
shown
within
box
fig
compris
autocatalyt
primari
cleavag
site
variou
studi
shown
peptid
bond
effici
cleav
furin
shown
vertic
arrow
vitro
ex
vivo
condit
addit
segment
furin
proregion
found
highli
conserv
across
speci
furinedapeptid
ii
contain
highli
reactiv
induc
unnatur
edaamino
acid
insert
scissil
argasp
amid
bond
like
peptid
analog
sensit
chang
ph
metal
ion
concentr
environment
condit
uv
light
may
lead
format
cyclic
deriv
iia
fig
via
bergman
cycloaromat
reaction
chemic
transform
modif
may
induc
proteas
inhibitori
activ
peptid
deriv
peptid
ii
synthes
hatudiea
diisopropyl
ethyl
amin
mediat
solid
phase
fmoc
chemistri
purifi
rphplc
fig
upper
panel
use
semiprepar
column
peak
elut
rt
min
collect
analyz
second
hplcrun
analyt
column
exhibit
singl
peak
nearli
ident
retent
time
show
high
degre
puriti
fig
lower
panel
ident
peptid
confirm
selditof
mass
spectrometri
display
peak
mz
consist
calcul
molecular
weight
mw
fig
second
peak
observ
mz
may
due
format
oxid
form
ii
sinc
mass
unit
higher
molecular
ion
howev
explan
may
also
exist
progress
curv
stoppedtim
assay
fluorogen
substrat
boc
butyloxi
rvrrmca
coumarin
fig
b
show
edapeptid
ii
inhibit
furin
activ
vitro
high
degre
potenc
progress
curv
assay
fig
indic
nm
ii
abl
block
furin
activ
almost
complet
substrat
measur
slope
curv
shown
within
parenthesi
graph
effect
found
concentrationdepend
measur
valu
found
nm
furthermor
dixon
plot
base
stoptim
assay
three
differ
substrat
concentr
fig
indic
inhibit
constant
ki
nm
furin
inhibit
ii
pattern
graph
also
confirm
competit
natur
inhibit
suggest
bind
edapeptid
catalyt
domain
furin
use
anoth
substrat
name
intramolecularli
quench
fluorogen
peptid
abz
benzoic
acid
tyx
tyrosin
deriv
human
sar
corona
viru
spike
protein
note
ii
block
process
measur
valu
nm
fig
fig
left
lower
panel
show
western
blot
result
use
flag
antibodi
effect
furinedapeptid
furin
process
flaglabel
propdgfa
cho
cell
result
compar
parallel
commerci
furin
inhibitor
dec
decanoyl
rvrrcmk
chloromethyl
keton
synthet
full
length
prodomain
protein
hfurin
like
two
inhibitor
edapeptid
also
abl
block
effici
cleavag
kda
propdgfa
kda
matur
pdgfa
fig
upper
panel
reflect
strong
appear
kda
propdgfa
band
complet
absent
control
experi
done
parallel
without
presenc
inhibitor
addit
fig
lower
panel
right
show
western
blot
use
vegfc
antibodi
effect
furinedapeptid
furinmedi
process
provegfc
cho
cell
effect
compar
parallel
done
known
furin
inhibitor
decrvrrcmk
figur
illustr
like
decrvrrcmk
furineda
peptid
abl
block
significantli
cleavag
kda
provegfc
kda
matur
vegfc
confirm
furin
inhibitori
activ
ex
vivo
condit
furinedapeptid
ii
also
abl
block
furinmedi
process
kda
propdgfb
kda
matur
form
cho
cell
concentrationdepend
manner
fig
result
highli
compar
conduct
parallel
protein
anoth
known
potent
inhibitor
furin
interest
note
neither
inhibitor
display
effect
format
kda
intermedi
form
pdgfb
whose
exact
ident
well
biolog
function
role
yet
fulli
explor
order
understand
plausibl
mechan
furin
inhibit
furinedapeptid
ii
recombin
furin
protein
incub
edapeptid
variou
concentr
h
mixtur
analyz
protein
band
silver
stain
western
blot
use
antifurin
antibodi
result
compar
recombin
furin
sampl
fresh
well
incub
absenc
edapeptid
western
blot
data
fig
left
lower
panel
indic
edapeptid
protect
furin
selfdegrad
kda
solubl
furin
band
gradual
becam
intens
concentr
edapeptid
increas
result
also
depict
densitometr
analysi
observ
band
fig
left
upper
panel
similar
conclus
also
reach
protein
stain
data
band
silver
ion
fig
right
panel
exhibit
intens
kda
furin
band
presenc
higher
concentr
edapeptid
energi
minim
model
structur
furinedapeptid
bergman
cycloaromat
reaction
comput
use
hyperchem
program
structur
depict
fig
show
cyclic
form
furinedapeptid
iia
exhibit
signific
chang
backbon
conform
geometri
particularli
ctermin
end
molecul
compar
correspond
acycl
form
ii
enediyn
known
undergo
bergman
cycoaromat
reaction
even
mild
condit
therefor
postul
observ
inhibit
furin
activ
furinedapeptid
may
mediat
cyclic
iia
rather
acycl
ii
form
postul
base
specul
potenc
bind
increas
upon
cycloaromat
reaction
due
increas
interact
work
use
proton
nmr
spectroscopi
would
necessari
provid
convinc
evid
hypothesi
howev
owe
proposit
dock
studi
perform
variou
domain
furin
particularli
pdomain
cycliz
furinedapeptid
iia
use
autodock
program
result
shown
fig
expand
reveal
effici
dock
potent
interact
ctermin
segment
furin
within
residu
detail
investig
reveal
strong
hbond
interact
among
sever
residu
within
domain
cycliz
furineda
peptid
fig
enlarg
portion
fact
dock
result
identifi
small
segment
interact
best
cycliz
eda
peptid
iia
signific
interact
notic
acycl
furinedapeptid
ii
suggest
possibl
iia
might
speci
respons
interact
furin
indic
may
ultim
lead
inhibit
furin
activ
compos
crucial
catalyt
residu
well
oxyanion
circular
dichroism
cd
spectrum
conduct
evalu
secondari
structur
furineda
peptid
might
play
role
furininhibitori
activ
cd
spectra
furineda
peptid
water
variou
ph
condit
depict
fig
spectra
show
peptid
exist
mostli
betasheet
random
structur
littl
helix
content
ph
condit
test
slight
chang
cd
profil
particularli
nm
area
follow
chang
ph
condit
may
possibl
due
partial
transform
sheet
structur
random
turn
structur
addit
fluorin
alcohol
tfe
helix
promot
solvent
led
format
signific
helic
structur
expens
sheet
structur
fig
observ
suggest
tfe
promot
helix
structur
furinedapeptid
might
alter
furin
inhibitori
properti
sinc
edapeptid
contain
aromat
conjug
doubl
tripl
bond
structur
decid
examin
fluoresc
spectroscop
properti
fact
found
exhibit
excit
emiss
peak
nm
respect
data
shown
emiss
spectra
furinedapeptid
tfe
absenc
presenc
variou
concentr
requir
furin
activ
shown
fig
graph
show
upon
addit
peak
nm
observ
emiss
spectrum
gradual
diminish
depend
amount
ad
fact
peak
complet
suppress
upon
addit
equimolar
quantiti
suggest
strong
interact
furinedapeptid
similar
conclus
also
reach
cd
spectra
studi
shown
studi
reveal
first
time
fulli
nonpeptid
aromat
heterocycl
enediyn
compound
inhibit
furin
activ
vitro
low
medium
micromolar
rang
depend
natur
structur
type
substitu
present
enzym
inhibitori
activ
also
notic
toward
pc
enzym
name
fig
among
compound
test
enediyn
heterocycl
ring
compound
bisbenzyl
substitu
found
exhibit
highest
inhibitori
activ
furin
respect
howev
found
less
potent
inhibitor
toward
thu
clearli
lack
select
inhibit
compar
among
pc
next
best
furin
inhibit
achiev
compound
follow
interestingli
contain
common
diaza
ring
structur
acycl
molecul
tetra
aza
compound
nickelcomplex
found
much
poor
inhibitor
furin
addit
studi
first
time
show
enedynyl
peptid
inhibit
proteas
activ
pc
enzym
furin
howev
manuscript
review
inhibit
chymotrypsin
enediynyl
peptid
report
literatur
thu
reveal
incorpor
enediynyl
eda
function
highli
reactiv
beta
turn
induc
amino
acid
junction
residu
furin
substrat
deriv
prodomain
primari
catalyt
site
led
highli
potent
furin
inhibitor
properli
design
unnatur
amino
acid
may
also
incorpor
instead
eda
design
furin
inhibitor
present
design
first
choic
prodomain
sequenc
compris
amino
acid
residu
human
preprofurin
select
substrat
signific
prodomain
well
remov
degrad
furin
activ
well
document
past
recent
present
data
base
progress
curv
dixon
plot
sigmoid
graph
fig
indic
furinedapeptid
ii
strong
inhibitor
proprotein
convertas
furin
furthermor
data
confirm
competit
natur
inhibit
also
support
cd
fluoresc
studi
data
also
suggest
furin
inhibit
edapeptid
independ
natur
substrat
use
small
peptid
physiolog
protein
fact
ii
inhibit
furin
cleavag
hsar
cov
peptid
well
physiolog
protein
substrat
growth
factor
precurs
although
present
studi
eda
introduc
amino
acid
logic
replac
substitut
residu
eda
expect
lead
even
potent
andor
select
inhibitor
furin
besid
peptid
substrat
furin
deriv
process
site
physiolog
proprotein
employ
valid
new
hypothesi
proteas
inhibitor
design
aspect
current
investig
laboratori
studi
involv
cell
line
express
furin
physiolog
substrat
propdgfa
provegfc
propdgfb
indic
edapeptid
ad
exogen
cultur
media
cell
growth
effici
block
furinmedi
process
substrat
lead
bioactiv
matur
form
concentr
depend
manner
case
effect
furineda
peptid
compar
observ
known
furin
inhibitor
decrvrrcmk
case
effect
slightli
less
pronounc
still
signific
thu
exampl
western
blot
result
show
edapeptid
block
furinmedi
process
provegfc
matur
vegfc
similar
extent
compar
obtain
decrvrrcmk
fig
similar
observ
also
note
propdgfa
process
howev
eda
peptid
found
effect
block
cleavag
propdgfb
fact
edapeptid
suppress
cleavag
propdgfb
matur
form
almost
ident
effici
fig
thu
vitro
ex
vivo
studi
involv
small
peptid
well
natur
protein
substrat
confirm
potent
antifurin
activ
edapeptid
ii
observ
ki
valu
edapeptid
measur
bocrvrrmca
found
higher
observ
bioengin
protein
still
low
nm
rang
studi
confirm
edapeptid
block
furin
cleavag
fluorogen
peptid
well
physiolog
relev
protein
propdgfa
b
provegfc
proteolyt
activ
growth
factor
precursor
protein
link
tumor
growth
progress
shown
high
level
express
matur
form
cancer
cell
compar
normal
one
thu
research
find
suggest
edapeptid
may
play
import
role
tumor
suppress
intervent
via
blockad
matur
furin
precursor
growth
factor
protein
potent
select
furin
inhibitor
base
eda
may
develop
choos
effici
furin
recognit
sequenc
base
known
substrat
secondari
structur
analysi
circular
dichroism
spectra
indic
edapeptid
exhibit
predominantli
sheet
random
structur
littl
content
helic
structur
aqueou
medium
physiolog
ph
condit
ph
chang
ph
littl
effect
secondari
structur
although
spectrum
profil
minima
show
signific
differ
moreov
addit
helix
promot
solvent
tfe
led
noteworthi
increas
helix
structur
therebi
suggest
edapeptid
capabl
adopt
helix
conform
depend
natur
ph
solvent
structur
behaviour
partli
consist
found
similar
region
furin
protein
reveal
xray
crystal
structur
molecular
dock
studi
indic
upon
bergman
cycliz
furinedapeptid
provid
potent
interact
better
contact
pdomain
furin
protein
character
segment
locat
distant
catalyt
domain
complet
catalyt
domain
furin
defin
sequenc
segment
begin
matur
nterminu
end
residu
equival
cterminu
thermitas
bind
may
lead
signific
chang
conform
fold
pattern
furin
catalyt
structur
lead
loss
proteas
activ
dock
could
notic
edapeptid
cyclic
acycl
form
domain
furin
thu
like
edapeptid
upon
bergman
cycliz
may
effect
inhibitor
furin
although
conclus
would
requir
studi
two
purifi
form
furineda
peptid
nmr
spectra
moreov
order
expand
present
studi
examin
efficaci
edapeptid
approach
gener
method
inhibitor
design
proteas
includ
furin
peptid
sequenc
need
examin
moreov
studi
futur
use
addit
cell
line
anim
model
shed
light
mechan
furin
inhibit
edapeptid
fmocprotect
amino
acid
deriv
lconfigur
coupl
reagent
resin
peptid
synthesi
well
fluorogen
substrat
bocrvrrmca
furin
inhibitor
decrvrrcmk
purchas
bachem
inc
king
prussia
pa
usa
calbiochem
novabiochem
inc
san
diego
ca
usa
neosystem
inc
san
diego
ca
usa
pe
appli
biosystem
foster
citi
ca
usa
primari
secondari
antibodi
pdgfb
actin
flag
tag
bought
santa
cruz
biotechnolog
inc
santa
cruz
ca
usa
wherea
reagent
immunoblot
sdspage
purchas
biorad
lab
hercul
ca
usa
surfac
enhanc
laser
desorpt
ioniz
matrix
assist
laser
desorpt
time
flight
mass
spectra
record
use
ciphergen
protein
chip
san
diego
ca
usa
voyageur
de
pro
peappli
biosystem
framingham
usa
respect
energi
absorb
matric
cinnam
acid
benzoic
acid
silica
gel
column
chromatographi
purchas
sigma
chemic
compani
mississauga
canada
sigmaaldrich
chemic
compani
st
loui
mo
usa
respect
solvent
use
hplc
grade
purchas
fisher
chemic
compani
mississauga
canada
rphplc
perform
column
analyt
semiprepar
use
varian
instrument
star
softwar
program
gradient
use
describ
chemic
synthes
full
character
variou
aryl
enediyn
compound
list
fig
accomplish
previous
use
multipl
chemic
step
describ
fmoc
enediynyl
amino
acid
eda
synthes
use
sever
step
describ
brief
synthesi
accomplish
first
pd
mediat
sonogashira
coupl
benzen
acid
benzhydryl
ester
presenc
cuprou
bromid
dri
triethylamin
reflux
condit
h
inert
atmospher
aqueou
work
crude
oili
residu
purifi
column
chromatographi
use
silica
gel
elut
petroleum
ether
ethyl
acet
afford
eneyn
ester
acid
benzhydryl
ester
second
round
sonogashira
coupl
eneyn
ester
subsequ
purif
yield
enediyn
hydroxyl
ester
phenyl
benzhydryl
ester
thu
enediyn
hydroxyl
ester
obtain
convert
methyl
toluen
sulphon
mesyl
subsequ
react
sodium
azid
dri
dmf
furnish
correspond
enediyn
azido
ester
phenyl
acid
benzhydryl
ester
azido
function
reduc
amin
treatment
triphenyl
phosphin
thf
amin
phenyl
acid
benzhydryl
ester
protect
fmoc
reaction
fmocchlorid
basic
condit
methanol
afford
fmocnhedabenzhydryl
ester
subject
deprotect
tfaanisol
dri
dichloromethan
furnish
desir
fmoceda
phenyl
acid
whose
calcul
molecular
weight
found
good
agreement
observ
molecular
weight
peptid
synthesi
accomplish
fmocbas
solid
phase
chemistri
mmol
scale
use
fmocpalpegp
polyamino
linker
polyethylen
glycol
resin
substitut
meqgm
resin
pal
methyl
phenoxi
valer
acid
peg
polyethylen
glycol
ps
polystyren
resin
hatu
ohexafluorophospho
n
n
n
ntetramethyluronium
diea
diisopropylethylamin
coupl
agent
follow
side
chain
protect
group
use
variou
fmoc
protect
amino
acid
tbutyloxi
carbonyl
tboc
ly
tertiari
butyl
tbut
thr
tyr
asp
glu
pbf
arg
final
trityl
trt
gln
follow
complet
synthesi
crude
peptid
cleav
resin
fulli
deprotect
reagent
b
crude
peptid
ii
obtain
purifi
rphplc
use
semiprepar
analyt
column
combin
peak
collect
examin
mass
spectrometri
peak
elut
retent
time
rt
min
character
furineda
peptid
ii
seldi
malditof
mass
spectrometri
use
chca
matrix
mw
calcul
observ
mh
mho
mhna
pure
solubl
recombin
h
human
furin
obtain
commerci
new
england
biolab
boston
usa
recombin
mous
solubl
obtain
partial
purifi
form
describ
earlier
inhibit
constant
ki
inactiv
furin
eda
peptid
ii
determin
dixon
plot
use
three
differ
concentr
substrat
bocrvrrmca
variou
concentr
inhibitor
rang
nm
determin
sigmoid
graph
gener
plot
reaction
rate
measur
raw
fluoresc
unit
rfu
releas
per
hour
logarithm
concentr
inhibitor
case
latter
substrat
use
intramolecularli
quench
fluorogen
peptid
abz
benzoic
acid
tyx
tyrosin
deriv
residu
hsar
corona
viru
spike
glycoprotein
previous
report
chocel
express
flagtag
pdgfa
grown
dmem
medium
describ
cell
achiev
confluenc
h
stage
medium
remov
cell
wash
grown
fresh
buffer
supplement
furineda
peptid
final
concentr
media
cell
harvest
anoth
h
cell
growth
collect
media
concentr
use
centricon
filtrat
system
amersham
bioscienc
inc
cut
mw
kda
subject
western
blot
analysi
use
flag
antibodi
presenc
full
length
propdgfa
ctermin
matur
form
obtain
follow
cleavag
endogen
furin
present
cho
cell
parallel
ident
experi
perform
grow
cell
absenc
presenc
known
furin
inhibitor
name
decrvrrcmk
concentr
synthet
full
length
furinprodomain
protein
final
concentr
previous
describ
us
quantit
purpos
sampl
also
analyz
presenc
actin
immunoblot
use
specif
antibodi
chocel
express
flaglabel
provegfc
grown
dmem
medium
describ
absenc
presenc
furineda
peptid
furin
inhibitor
decrvrrcmk
concentr
presenc
vegfc
precursor
ctermin
process
form
gener
furin
cleavag
assess
western
blot
analysi
use
flag
antibodi
level
actin
control
hous
keep
protein
analyz
immunoblot
quantit
purpos
chocel
express
endogen
propdgfb
grown
describ
absenc
presenc
variou
concentr
rang
either
furineda
peptid
known
furin
inhibitor
western
blot
perform
presenc
propdgfb
process
form
use
pdgfb
specif
antibodi
parallel
sampl
also
analyz
actin
level
recombin
ctermin
truncat
solubl
furin
activ
unit
mw
kda
u
activ
releas
pmol
free
amc
fluorogen
bocrvrrmca
substrat
one
minut
incub
h
mm
tri
mm
me
mm
ph
absenc
presenc
furinedapeptid
ii
variou
concentr
rang
sampl
analyz
western
blot
use
furin
antibodi
santacruz
well
silver
stain
presenc
protein
band
cd
spectra
run
triplic
averag
record
spectropolarimet
easton
md
usa
cm
thick
rectangular
quartz
cell
total
volum
final
concentr
nm
interv
nm
wave
length
final
correct
cd
spectra
obtain
subtract
spectrum
control
solvent
run
parallel
sampl
spectrum
analyz
use
cd
estima
contin
softwar
program
sheet
random
structur
use
softspec
compani
nj
usa
fluoresc
emiss
spectrum
furineda
peptid
mm
record
fix
excit
wave
length
nm
well
plate
tetrafluoro
ethanol
tfe
solvent
ambient
temperatur
absenc
presenc
ad
solut
mm
stock
solut
theoret
molecular
model
structur
gener
edapeptid
acycl
ii
cyclic
iia
form
use
hyperchem
softwar
version
hypercub
inc
base
energi
minim
use
polakribier
algorithm
program
dock
edapeptid
acycl
cyclic
form
catalyt
domain
hfurin
sequenc
access
number
base
known
crystal
structur
pdb
file
accomplish
use
autodock
model
program
compar
protein
structur
model
satisfact
spatial
restraint
http
salilaborgmodel
